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Abstract: 
 A diverse series of chalcones of dehydroacetic acid were synthesized and subjected to antioxidant activity. 
Highest DPPH scavenging effect was observed in case of HR 4 displaying IC50 of 4.18 mg/ml in comparison to the 
standard ascorbic acid (IC50 0f 4.04 mg/ml). However, the highest hydroxyl radical scavenging effect was displayed by 
HR 25 exhibiting (IC50  10.21). Keeping in view the very low cytotoxicity issues of most of the chalcone derivatives of 
dehydroacetic acid, this study provides an important aspect with regard to the use of dehydroacetic acid-based 
derivatives as antioxandts. 
Keywords: Dehydoacetic acid, Chalcone, Anti-Oxidant, Cytotoxicity, DPPH. 
Introduction: 
4-Hydroxy-2-pyrones are the most abundant and biologically most significant class of 2-pyrones [1-3] e.g., 
Fusapyrone and Deoxyfusapyrone (Figure 1), isolated from the rice cultures of Fusarium semitectum [4]. They 
show considerable anti-fungal activity with high selectivity and low toxicity [5]. 4-Hydroxy-2pyrone represents 
the active component of naturally isolated anti-TB agents like Pseudo pyronine B [6,7] and Myxopyronin [8,9] 
and clinically approved anti-HIV agent like Tipranavir [10,11] (Figure 1). 
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Figure 1: Some biologically significant 4-hydroxy-2-pyrones 
Chalcones of dehydroacetic acid are well known for their anti-TB [12], anti-cancer[13,14], and anti-microbial 
[15] and anti-HIV [16] activities. Because of the above-mentioned biological properties, it is envisaged that the 
chalcone serivatives of dehyroacetic acid could be further investigated to explore its additional biological 
properties. A thorough literature survey revealed that anti-oxidant properties of chalcones of dehydroacetic 
acid were yet to be investigated. Keeping this fact in mind as well as our previous work on 2-pyrones [17-20], 
we directed our studies towards the syntheis of a diverse series of chalcones of dehydroacetic acid of 
biological interest. All the synthesized analogs were subjected to DPPH and hydroxyl radical scavenging assay 
to check their anti-oxidant potential. This work provides a report on SAR of chalcones of dehyroacetic acid to 
come up with analogs having better activity, and improved selectivity. 
Results and discussion 
Chalcones of 3-Acetyl-4-hydroxy-6-methyl-2-pyrone (1) were synthesized by classical Clasein Schmidt condensation 
in good to excellent yields by treating 1 equivalent of (1) with aromatic aldehydes (1.1 equiv.) in ethanol in prence of 
catalytic amount of piperidine. The reaction mixture was heated at 60 0C for 1-4 hours (Figure 2).  
 
Figure 2: general reaction for the synthesis of chalcones 
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Completion of the reaction was monitored of TLC. After the completion, the desired product was purified by column 
chromatography technique using Hexane: Ethylacetate as eluent. A library of 25 chalcones (HR1-HR25) enlisted in 
(Table 1) were synthesized for biological screening. The products formed were easily confirmed by 1H and 13CNMR 
spectra. 
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Table 1: Library of synthesized chalcones  of 3-Acetyl-4-hydroxy-6-methyl-2-pyrone. 
All the synthesized derivatives were subjected to antioxidant activity using DPPH scavenging assay and Hydroxy 
radical scavenging assay. To evaluate their DPPH scavenging effect, the derivatives were screened at different 
concentrations to obtain their IC50 values, as shown (Table 2). 
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   Ascorbic acid was used as positive control in this assay. Amongst the synthesied derivatives a notable difference in 
DPPH scavenging was observed which may be attributed to the type of the aldeyde and position and the type of 
substituent in the aldehyde used. Amongst the derivatives HR 4 (4- Hydroxy aldehyde analog) was found to be most 
active with an IC50 of 4.58 although less than the control used but still very comperative. The ortho-hydrxy 
benzaldehyde derivate HR 19 and meta-hydroxy benzaldehyde derivative HR 20 were less active displaying IC50 
values of 5.1 mg/ml and 6.9 mg/ml respectively. The next active analog of the series was found to be HR 25 with an 
IC50 value 4.69. The effect of substituents had hardly any effect on the antioxidant activity. However, the hydroxyl 
benzaldehyde derivatives were found to comparatively more active than other analogs of aromatic aldehydes. The   
results have been summed up in table 2. 
S. No Compound DPPH  Assay 
IC50 (µg/ml) 
OH Radical Assay 
IC50 (µg/ml) 
01 HR 1 8.06 82.4 
02 HR 2 12.23 45.4 
03 HR 3 15.22 62.3 
04 HR 4 4.58 13.4 
05 HR 5 16.7 21.2 
06 HR 6 22.32 15.2 
07 HR 7 15.42 23.3 
08 HR 8 8.67 25.4 
09 HR 9 6.53 69.7 
10 HR 10 10.43 56.6 
11 HR 11 6.33 12.3 
12 HR 12 25.4 17.6 
13 HR 13 6.67 19.3 
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14 HR 14 12.32 16.7 
15 HR 15 9.82 66.9 
16 HR 16 6.34 82.3 
17 HR 17 7.21 15.2 
16 HR 18 5.69 36.4 
19 HR 19 5.14 13.5 
20 HR 20 6.89 15.3 
21 HR 21 7.22 35.9 
22 HR 22 8.21 21.4 
23 HR 23 8.78 12.4 
24 HR 24 8.67 13.2 
25 HR 25 4.69 10.2 
Table 2. DPPH and OH radical scavenging potential of derivatives of dehydro acetic acid 
These derivatives were further subjected to hydroxyl scavenging effect at different concentrations, the IC50 
values are shown in (Table 2). Again, ascorbic acid was taken as control in this assay. 4-Hydroxy 3- methoxy 
benzaldehyde derivate HR 25 of dehyroacetic acid displayed the highest hydroxyl radical scavenging activity 
with an IC50 of 10.21 which is in comparative to the OH radical scavenging value of ascorbic acid. From the 
table it is clear that the hydroxyl radical scavenging capacity is independent of the nature and position of the 
substituents. However, it is clear that the hydroxy benzaldehyde substituents have displayed better ability of 
hydroxyl radical scavenging. All the results have been summed in Table 2 above. 
Conclusion: 
In coclusion, a diverse series of chalcones of dehroacetic acid (DHA) has been developed using piperidine as 
catalyst. Among all the derivatives, (E)-4-hydroxy-3-(3-(4-hydroxyphenyl)acryloyl)-6-methyl-2H-pyran-2-one 
(HR 4) showed the highest DPPH scavenging (IC50 of 4.58), while as (E)-4-hydroxy-3-(3-(4-hydroxy-3-
methoxyphenyl)acryloyl)-6-methyl-2H-pyran-2-one (HR 25) displayed the best OH radical scavenging with IC50 
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of 10.21 which is very close to the IC50 values of ascorbic acid used as standard. Owing to the fact that these 
chalcones exhibit very low cytotoxity, they show a promising potential in getting expored in food industry.  
Supporting Information: 
Experimental section including synthesis and antioxidant activity of chalcones of dehydroacetic acid, 1H and 
13CNMR spectra of the synthesised compounds can be found associated with this article as supplementary 
data. 
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Supporting Information 
General experimental procedures 
All the solvents and reagents for the preparation of the extracts, chemical synthesis and biological assays were 
purchased from Sigma Aldrich. The chemical reactions were monitored using F254 silica gel TLC plates (E. Merck) 
with ceric ammonium sulphate as charring agent and UV chamber (366 and 254 nm) for the detection of spots. The 
synthesized products were purified using column chromatography on silica gel (60–120 mesh). 1H NMR and 13C 
NMR spectra (chemical shifts expressed in ppm and coupling constants in Hertz) were recorded on Bruker DPX 400 
instrument using MeOD as the solvent with TMS as the internal standard. IR was recorded on Cary 630 FT-IR 
Spectrometer and Mass spectra were carried out on LC–MS 8030 tandem mass spectrometer manufactured by 
Shimadzu Corporation, Kyoto, Japan. All the compounds were analysed in full scan mode with nitrogen serving as 
interface gas. Detection was done in ESI mode having probe voltage of 180.0 V, with probe temperature of 400 C. 
Chemicals used: 2, 2-diphenyl-1-picryl hydrazyl (DPPH), ascorbic acid, dry ferric chloride, ferric nitrate, Potassium 
ferricyanide (1% w/v), phosphate buffer (0.2 M, pH 6.6), TCA, trichloro acetic acid (10%), ferric chloride (0.1%). 
General procedure for the synthesis of pyrone based chalcone derivatives: 
To a mixture of 3-acetyl-6-methypyron-2-one (1 equiv) and aromatic aldehyde (1 equiv) in ethanol (2 mL), catalytic 
amount of piperidine was added. The reaction mixture was allowed to stir at 60 oC for 1 to 4 hrs. The progress of the 
reaction was monitored using TLC. After the completion of the reaction as monitored by TLC, ethanol was 
evaporated and the crude mixture was subjected to column chromatography (petroleum ether/EtOAc) to obtain the 
desired product. 
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 Spectral analysis: 
3-cinnamoyl-4-hydroxy-6-methyl-2H-pyran-2-one (HR 1): 
1H NMR (400 MHz, CDCl3) δ 8.30 (d, J = 15.7 Hz, 1H), 7.94 (d, J = 15.8 Hz, 1H), 7.67 (dd, J=6.5, 2.8 Hz, 2H), 7.39 (dd, J 
= 11.3, 7.7 Hz, 3H), 5.94 (s, 1H), 2.26 (s, 3H). 13C NMR (101 MHz,CDCl3) δ 193.04, 183.40, 168.90, 161.44, 146.56, 
134.97, 131.33, 129.42 (2 x C), 129.18 (2 xC), 123.25, 102.62, 99.70, 20.87. ESI MS (m/z): 256 [M+Na]+. Anal. Calc. for 
C15H12O4: C,70.31; H, 4.72; Found C,70.38; H, 4.68. 
(E)-4-hydroxy-6-methyl-3-(3-(p-tolyl)acryloyl)-2H-pyran-2-one (HR 2): 
1H NMR (400 MHz, CDCl3) δ 8.30 (d, J = 15.7 Hz, 1H), 7.98 (d, J = 15.7 Hz, 1H), 7.61 (d, J=7.8 Hz, 2H), 7.32 – 7.22 (m, 
2H), 5.97 (s, 1H), 2.42 (s, 3H), 2.30 (s, 3H). 13C NMR (101 MHz,CDCl3) δ 192.96, 183.50, 168.70, 161.49, 146.83, 142.12, 
132.30, 129.95 (2 x C), 129.52 (2 xC), 122.10, 102.71, 99.64, 77.55, 77.23, 76.92, 21.84, 20.84. ESI MS (m/z): 270 [M+Na] 
+. Anal.Calc. for C16H14O4: C, 71.10; H, 5.22; Found C,71.17; H, 5.27. 
(E)-3-(3-(4-ethoxyphenyl)acryloyl)-4-hydroxy-6-methyl-2H-pyran-2-one (HR 3): 
1H NMR (400 MHz, CDCl3) δ 8.18 (d, J = 15.6 Hz, 1H), 7.94 (d, J = 15.7 Hz, 1H), 7.63 (t, J =7.8 Hz, 2H), 6.90 (d, J 
= 8.7 Hz, 2H), 5.91 (d, J = 2.6 Hz, 1H), 4.11 – 4.02 (m, 2H), 2.25 (s, 3H),1.45 – 1.37 (m, 3H). 13C NMR (101 MHz, 
CDCl3) δ 192.92, 183.35, 168.68, 161.59, 159.53,146.37, 136.32, 130.10, 123.59, 122.08, 117.89, 114.54, 102.79, 
99.82, 63.83, 20.83, 14.98. ESI MS (m/z): 300 [M+Na]+. Anal. Calc. for C17H16O5: C, 67.99; H, 5.37; Found 
C,70.38; H, 4.68 
(E)-4-hydroxy-3-(3-(4-hydroxyphenyl)acryloyl)-6-methyl-2H-pyran-2-one (HR 4): 
1H NMR (400 MHz, DMSO) δ 10.29 (s, 1H, -OH), 8.03 (d, J = 15.7 Hz, 1H), 7.90 (d, J = 15.7Hz, 1H), 7.61 (d, J = 
8.4 Hz, 2H), 6.87 (d, J = 8.4 Hz, 2H), 6.27 (s, 1H), 2.26 (s, 3H). 13C NMR (101 MHz, DMSO) δ 191.58, 182.76, 
169.51, 161.10, 160.59, 146.54, 131.39 (2 x C), 125.41, 118.69, 116.23 (2 x C), 102.03, 98.69, 20.01. ESI MS (m/z): 
272 [M+Na]+. Anal. Calc. for C15H12O5: C, 66.17; H, 4.44; Found C,66.12; H, 4.40. 
(E)-3-(3-(furan-2-yl)acryloyl)-4-hydroxy-6-methyl-2H-pyran-2-one (HR 5): 
1H NMR (400 MHz, CDCl3) δ 8.11 (d, J = 15.4 Hz, 1H), 7.70 (d, J = 15.4 Hz, 1H), 7.56 (s, 1H), 6.78 (d, J = 2.3 Hz, 1H), 
6.50 (s, 1H), 5.92 (s, 1H), 2.25 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 192.35, 183.41, 168.71, 161.32, 152.07, 146.30, 
132.17, 120.68, 117.70, 113.13, 102.68, 99.0, 77.55, 77.23, 76.91, 20.84. C13H10O5 246. ESI MS (m/z): 246 [M+Na]+.  
Anal. Calc. for C13H10O5: C, 63.42; H, 4.09; Found C,63.47; H, 4.03. 
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(E)-4-hydroxy-6-methyl-3-(3-(thiophen-3-yl)acryloyl)-2H-pyran-2-one (HR 6): 
1H NMR (400 MHz, CDCl3) δ 8.09 (d, J = 15.6 Hz, 1H), 7.93 (d, J = 15.6 Hz, 1H), 7.65 (s, 1H), 7.46 (d, J = 4.2 Hz, 
1H), 7.34 (s, 1H), 5.92 (s, 1H), 2.25 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 193.10, 183.40, 168.73, 161.44, 139.82, 
138.61, 130.69, 127.27, 126.19, 122.90, 102.67, 99.61, 20.83. C13H10O4S 262. ESI MS (m/z): 262 [M+Na]+. Anal. 
Calc. for C13H10O4S: C, 59.53; H, 3.84; Found C,59.58; H, 3.88. 
(E)-4-hydroxy-3-(3-(2-methoxyphenyl)acryloyl)-6-methyl-2H-pyran-2-one (HR 7): 
1HNMR (400 MHz, CDCl3) δ 8.35 (s, 2H), 7.71 (d, J = 7.7 Hz, 1H), 7.38 (t, J = 7.2 Hz, 1H), 6.98 (t, J = 7.5 Hz, 1H), 
6.91 (d, J = 8.3 Hz, 1H), 5.92 (s, 1H), 3.91 (s, 3H), 2.25 (s, 3H). 13CNMR (101 MHz, CDCl3) δ 193.20, 183.59, 
168.55, 161.49, 159.34, 141.96, 132.79, 129.79, 124.01, 123.22, 121.04, 111.42, 102.76, 101.66, 55.78, 20.81. ESI 
MS (m/z): 268 [M+Na]+. Anal. Calc. for C16H14O5: C, 67.13; H, 4.93; Found C,67.17; H, 4.90. 
(E)-4-hydroxy-6-methyl-3-(3-(2-(trifluoromethyl)phenyl)acryloyl)-2H-pyran-2-one (HR 8): 
1H NMR (400 MHz, CDCl3) δ 8.27 (bs, 2H), 7.93 (d, J = 7.4 Hz, 1H), 7.70 (d, J = 7.3 Hz, 1H), 7.59 (t, J = 7.0 Hz, 
1H), 7.50 (d, J = 7.2 Hz, 1H), 5.96 (s, 1H), 2.27 (s, 3H). 13CNMR (101 MHz, CDCl3) δ 192.79, 183.15, 169.35, 
161.45, 141.05, 132.39, 130.33 (2 x C), 128.84 (2 x C), 127.29, 126.45, 126.39, 102.44, 99.87, 20.92. ESI MS (m/z): 
324 [M+Na]+. Anal. Calc. for C16H11F3O4: C, 59.27; H, 3.42; Found C,59.21; H, 3.48. 
(E)-4-hydroxy-6-methyl-3-(3-(3-(trifluoromethyl)phenyl)acryloyl)-2H-pyran-2-one (HR 9): 
1H NMR (400 MHz, CDCl3) δ 8.32 (d, J = 15.8 Hz, 1H), 7.91 (d, J = 15.0 Hz, 1H), 7.85 (d, J = 7.1 Hz, 2H), 7.64 (d, J 
= 7.6 Hz, 1H), 7.52 (t, J = 7.8 Hz, 1H), 5.96 (s, 1H), 2.27 (s, 3H). 13CNMR (101 MHz, CDCl3) δ 192.85, 183.17, 
169.34, 161.40, 144.15, 135.77, 131.86, 129.70, 127.48, 127.44, 126.10, 126.06, 125.20, 102.44, 99.81, 20.91. ESI 
MS (m/z): 324 [M+Na]+. Anal. Calc. for C16H11F3O4: C, 59.27; H, 3.42; Found C,59.22; H, 3.46. 
(E)-4-hydroxy-6-methyl-3-(3-(4-(trifluoromethyl)phenyl)acryloyl)-2H-pyran-2-one(HR 10): 
1HNMR (400 MHz, CDCl3) δ 8.34 (d, J = 15.7 Hz, 1H), 7.89 (d, J = 15.7 Hz, 1H), 7.75 (d, J = 7.2 Hz, 2H), 7.64 (d, J 
= 7.1 Hz, 2H), 5.96 (s, 1H), 2.27 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 192.87, 183.17, 169.41, 161.39, 143.98, 
138.31, 129.34 (2 x C), 126.15, 126.12, 126.08, 126.04, 125.85, 102.43, 99.86, 20.92. ESI MS (m/z): 324 [M+Na]+. 
Anal. Calc. for C16H11F3O4: C, 59.27; H, 3.42; Found C,59.30; H, 3.44. 
(E)-4-hydroxy-3-(3-(2-methoxy-4-(trifluoromethyl)phenyl)acryloyl)-6-methyl-2H-pyran-2-one (HR 11): 
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1H NMR (400 MHz, CDCl3) δ 8.39 (d, J = 15.9 Hz, 1H), 8.24 (d, J = 16.0 Hz, 1H), 7.79 (d, J = 7.9 Hz, 1H), 7.23 (d, J 
= 7.4 Hz, 2H), 7.11 (s, 1H), 5.95 (s, 1H), 3.95 (s, 3H), 2.27 (s, 3H). 13CNMR (101 MHz, CDCl3) δ 193.17, 183.33, 
169.08, 161.44, 158.97, 139.69, 129.88 (2 x C), 127.34, 125.76 (2 x C), 117.72, 108.23, 102.56, 99.86, 56.12, 20.89. 
ESI MS (m/z): 354 [M+Na]+. Anal. Calc. for C17H13F3O5: C, 70.3157.63; H, 3.70; Found C,57.67; H, 3.75. 
 
(E)-3-(3-(4-bromothiophen-2-yl)acryloyl)-4-hydroxy-6-methyl-2H-pyran-2-one (HR 12): 
1H NMR (400 MHz, CDCl3) δ 7.95 (q, J = 15.4 Hz, 2H), 7.13 (d, J = 3.6 Hz, 1H), 7.04 (d, J = 3.7 Hz, 1H), 5.93 (s, 
1H), 2.26 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 192.09, 183.27, 168.94, 161.36, 142.36, 137.68, 133.13, 131.72, 
122.27, 118.57, 102.59, 99.87, 20.89. ESI MS (m/z): 341 [M+Na]+. Anal. Calc. for C13H9BrO4S: C, 45.76; H, 2.66; 
Found C,45.79; H, 2.60. 
(E)-3-(3-(3-bromophenyl)acryloyl)-4-hydroxy-6-methyl-2H-pyran-2-one (HR 13): 
1H NMR (400 MHz, CDCl3) δ 8.25 (d, J = 15.7 Hz, 1H), 7.88 – 7.74 (m, 2H), 7.57 (d, J = 7.6 Hz, 1H), 7.51 (d, J = 
7.7 Hz, 1H), 7.32 – 7.20 (m, 1H), 5.95 (s, 1H), 2.26 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 192.83, 183.22, 169.22, 
161.38, 144.42, 137.07, 133.94, 131.94, 130.64, 127.79, 124.71, 123.31, 102.48, 99.78, 20.91. ESI MS (m/z): 335 
[M+Na]+. Anal. Calc. for C15H11BrO4: C, 53.76; H, 3.31; Found C,53.70; H, 3.30. 
(E)-3-(3-(4-bromophenyl)acryloyl)-4-hydroxy-6-methyl-2H-pyran-2-one (HR 14): 
1H NMR (400 MHz, CDCl3) δ 8.27 (d, J = 15.7 Hz, 1H), 7.84 (d, J = 15.7 Hz, 1H), 7.52 (s, 4H), 5.94 (s, 1H), 2.26 (s, 
2H). 13C NMR (101 MHz, CDCl3) δ 192.84, 183.27, 169.08, 161.41, 144.86, 133.88 (2 x C), 132.44, 130.65 (2 x C), 
125.70, 123.90, 102.53, 99.72, 20.88. ESI MS (m/z): 335 [M+Na]+. Anal. Calc. for C15H11BrO4: C, 53.76; H, 3.31; 
Found C,53.72; H, 3.30. 
(E)-4-hydroxy-3-(3-(3-methoxyphenyl)acryloyl)-6-methyl-2H-pyran-2-one (HR 15): 
1H NMR (400 MHz, CDCl3) δ 8.28 (t, J = 15.5 Hz, 1H), 7.89 (d, J = 15.7 Hz, 1H), 7.35 – 7.22 (m, 2H), 7.14 (d, J = 
16.7 Hz, 1H), 6.92 (dd, J = 20.2, 8.0 Hz, 1H), 5.93 (s, 1H), 3.82 (s, 3H), 2.25 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 
192.93, 183.32, 168.90, 161.37, 160.12, 146.39, 136.29, 130.11, 123.48, 122.11, 117.37, 113.94, 102.55, 99.67, 
55.53, 20.81. ESI MS (m/z): 286 [M+Na]+. Anal. Calc. for C16H14O5: C, 67.13; H, 4.93; Found C,67.16; H, 4.90. 
(E)-4-hydroxy-3-(3-(4-methoxyphenyl)acryloyl)-6-methyl-2H-pyran-2-one (HR 16): 
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1H NMR (400 MHz, CDCl3) δ 8.18 (d, J = 15.6 Hz, 1H), 7.93 (d, J = 15.7 Hz, 1H), 7.63 (d, J = 8.7 Hz, 2H), 6.91 (d, J 
= 8.7 Hz, 2H), 5.92 (s, 1H), 3.84 (s, 3H), 2.25 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 192.65, 183.61, 168.47, 
162.54, 161.56, 146.72, 131.43, 127.82, 120.56, 114.70, 102.83, 99.51, 55.66, 29.90, 20.80. ESI MS (m/z): 286 
[M+Na]+. Anal. Calc. for C16H14O5: C, 67.13; H, 4.93; Found C,67.15; H, 4.96. 
(E)-4-hydroxy-6-methyl-3-(3-(m-tolyl)acryloyl)-2H-pyran-2-one (HR 17): 
1H NMR (400 MHz, CDCl3) δ 8.31 (d, J = 15.7 Hz, 1H), 7.95 (d, J = 15.7 Hz, 1H), 7.57 – 7.47 (m, 2H), 7.29 (dt, J = 
16.7, 7.5 Hz, 2H), 5.97 (s, 1H), 2.41 (s, 3H), 2.29 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 192.94, 183.38, 168.78, 
161.40, 146.81, 138.83, 134.86, 132.21, 129.81, 129.01, 126.78, 122.90, 102.60, 99.63, 21.46, 20.79. ESI MS (m/z): 
270 [M+Na]+. Anal. Calc. for C16H14O4: C, 71.10; H, 5.22; Found C,71.14; H, 5.27. 
(E)-3-(3-(2-chlorophenyl)acryloyl)-4-hydroxy-6-methyl-2H-pyran-2-one (HR 18): 
1H NMR (400 MHz, CDCl3) δ 8.29 (d, J = 15.8 Hz, 1H), 8.20 (d, J = 15.7 Hz, 1H), 7.77 (dd, J = 7.2, 2.0 Hz, 1H), 
7.38 – 7.31 (m, 1H), 7.29 – 7.17 (m, 2H), 5.89 (s, 1H), 2.20 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 192.83, 183.20, 
169.12, 161.37, 141.65, 136.10, 133.09, 131.88, 130.37, 128.62, 127.36, 125.56, 102.47, 99.77, 20.85. ESI MS 
(m/z): 290 [M+Na]+. Anal. Calc. for C15H11ClO4: C, 61.98; H, 3.81; Found C,61.92; H, 3.86 
(E)-4-hydroxy-3-(3-(2-hydroxyphenyl)acryloyl)-6-methyl-2H-pyran-2-one (HR 19): 
1H NMR (400 MHz, DMSO) δ 10.49 (s, 1H, -OH), 8.29 (d, J = 15.9 Hz, 1H), 8.18 (d, J = 15.9 Hz, 1H), 7.59 (d, J = 
7.6 Hz, 1H), 7.31 (t, J = 7.7 Hz, 1H), 7.02 – 6.85 (m, 2H), 6.29 (s, 1H), 3.32 (s, 1H, -OH), 2.27 (s, 3H). 13C NMR (101 
MHz, DMSO) δ 192.24, 182.70, 169.73, 160.47, 157.86, 141.67, 132.90, 129.36, 121.90, 121.12, 119.66, 116.45, 
101.94, 98.91, 20.04. ESI MS (m/z): 272 [M+Na]+. Anal. Calc. for C15H12O5: C, 66.17; H, 4.44; Found C,66.12; H, 
4.40. 
(E)-4-hydroxy-3-(3-(3-hydroxyphenyl)acryloyl)-6-methyl-2H-pyran-2-one (HR 20): 
1H NMR (400 MHz, DMSO) δ 9.73 (s, 1H, -OH), 8.13 (d, J = 15.8 Hz, 1H), 7.83 (d, J = 15.8 Hz, 1H), 7.34 – 7.23 (m, 
1H), 7.14 (d, J = 6.6 Hz, 2H), 6.95 – 6.87 (m, 1H), 6.31 (s, 1H), 2.28 (s, 3H). 13C NMR (101 MHz, DMSO) δ 192.03, 
182.46, 170.08, 160.62, 157.86, 145.66, 135.53, 130.28, 122.67, 120.62, 118.79, 114.27, 101.85, 99.10, 20.09. ESI 
MS (m/z): 272 [M+Na]+. Anal. Calc. for C15H12O5: C, 66.17; H, 4.44; Found C,66.16; H, 4.41. 
(E)-3-(3-(3-ethoxyphenyl)acryloyl)-4-hydroxy-6-methyl-2H-pyran-2-one (HR 21): 
1H NMR (400 MHz, CDCl3) δ 8.26 (t, J = 16.0 Hz, 1H), 7.87 (d, J = 15.7 Hz, 1H), 7.26 (dt, J = 7.4, 5.8 Hz, 2H), 7.15 
(s, 1H), 6.93 (d, J = 7.8 Hz, 1H), 5.92 (s, 1H), 4.06 (p, J = 7.0 Hz, 2H), 2.24 (s, 3H), 1.40 (t, J = 7.0 Hz, 3H). 13C NMR 
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(101 MHz, CDCl3) δ 192.92, 183.35, 168.68, 161.59, 159.53, 146.37, 136.32, 130.10, 123.59, 122.08, 117.89, 
114.54, 102.79, 99.82, 63.83, 20.83, 14.98. ESI MS (m/z): 300[M+Na]+. Anal. Calc. for C17H16O5: C, 67.99; H, 
5.37; Found C,67.92; H, 5.31. 
(E)-3-(3-(2,5-dimethoxyphenyl)acryloyl)-4-hydroxy-6-methyl-2H-pyran-2-one (HR 22): 
1H NMR (400 MHz, CDCl3) δ 8.37 – 8.25 (m, 2H), 7.29 – 7.18 (m, 1H), 6.94 (dd, J = 9.0, 3.0 Hz, 1H), 6.84 (d, J = 
9.0 Hz, 1H), 5.92 (s, 1H), 3.86 (s, 3H), 3.80 (s, 3H), 2.25 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 193.11, 183.54, 
168.60, 161.49, 153.99, 153.79, 141.69, 124.50, 123.41, 119.00, 113.57, 112.76, 102.74, 99.70, 56.36, 56.07, 20.81. 
ESI MS (m/z): 316 [M+Na]+. Anal. Calc. for C17H16O6: C, 64.55; H, 5.10; Found C,64.51; H, 5.14. 
(E)-4-hydroxy-6-methyl-3-(3-(2,4,5-trimethoxyphenyl)acryloyl)-2H-pyran-2-one (HR 23): 
1H NMR (400 MHz, CDCl3) δ 8.41 (d, J = 15.8 Hz, 1H), 8.26 (d, J = 15.7 Hz, 1H), 7.24 (s, 1H), 6.54 (s, 1H), 5.97 (s, 
1H), 3.99 (s, 2H), 3.96 (s, 3H), 3.95 (s, 3H), 2.30 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 192.52, 183.85, 168.09, 
161.75, 155.68, 153.87, 143.74, 141.97, 119.98, 115.83, 111.39, 103.09, 99.48, 96.76, 56.72, 56.60, 56.33, 20.78. 
ESI MS (m/z): 346 [M+Na]+. Anal. Calc. for C18H18O7: C, 62.42; H, 5.25; Found C,62.47; H, 5.20. 
(E)-4-hydroxy-6-methyl-3-(3-(3,4,5-trimethoxyphenyl)acryloyl)-2H-pyran-2-one (HR 24): 
1H NMR (400 MHz, CDCl3) δ 8.19 (d, J = 15.6 Hz, 1H), 7.86 (d, J = 15.6 Hz, 1H), 7.25 (d, J = 4.3 Hz, 1H), 6.88 (s, 
2H), 5.94 (s, 1H), 3.87 (s, 3H), 3.88 (s, 3H), 3.89 (s, 3H), 2.26 (s, 1H). 13C NMR (101 MHz, CDCl3) δ 192.69, 183.43, 
168.78, 161.58, 153.67, 146.69, 141.34, 130.45, 122.36, 106.65, 102.71, 99.64, 61.23, 56.46, 20.85. ESI MS (m/z): 
346 [M+Na]+. Anal. Calc. for C18H18O7: C, 62.42; H, 5.25; Found C,62.45; H, 5.22. 
(E)-4-hydroxy-3-(3-(4-hydroxy-3-methoxyphenyl)acryloyl)-6-methyl-2H-pyran-2-one (HR 25): 
1H NMR (400 MHz, CDCl3) δ 8.16 (d, J = 15.6 Hz, 1H), 7.88 (d, J = 15.6 Hz, 1H), 7.31 (t, J = 6.0 Hz, 1H), 7.20 (dd, 
J = 8.4, 1.8 Hz, 1H), 5.92 (s, 1H), 5.62 (s, 1H, -OH), 3.93 (s, 3H), 2.25 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 192.71, 
183.60, 168.58, 161.51, 149.64, 146.84, 146.17, 128.79, 123.53, 121.28, 114.52, 110.81, 102.80, 99.59, 56.30, 
20.85. ESI MS (m/z): 302 [M+Na]+. Anal. Calc. for C16H14O6: C, 63.57; H, 4.67; Found C,63.52; H, 4.61. 
Representative Specctra 
1HNMR and 13CNMR of 3-cinnamoyl-4-hydroxy-6-methyl-2H-pyran-2-one  
1HNMR of  
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13CNMR  
 
1HNMR and 13CNMR of  (E)-3-(3-(furan-2-yl)acryloyl)-4-hydroxy-6-methyl-2H-pyran-2-one  
1HNMR  
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13CNMR  
 
1HNMR and 13CNMR of (E)-4-hydroxy-6-methyl-3-(3-(2-(trifluoromethyl)phenyl)acryloyl)-2H-pyran-2-one 
                                                                    HNMR 
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1   
13CNMR  
 
1HNMR and 13CNMR of (E)-3-(3-(4-bromothiophen-2-yl)acryloyl)-4-hydroxy-6-methyl-2H-pyran-2-one  
1HNMR  
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HNMR and CNMR of (E)-3-(3-(3-bromophenyl)acryloyl)-4-hydroxy-6-methyl-2H-pyran-2-one  
1HNMR  
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13CNMR  
 
1HNMR and 13CNMR of (E)-3-(3-(3-ethoxyphenyl)acryloyl)-4-hydroxy-6-methyl-2H-pyran-2-one  
1HNMR  
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13CNMR  
 
1HNMR and 13CNMR of  (E)-3-(3-(2,5-dimethoxyphenyl)acryloyl)-4-hydroxy-6-methyl-2H-pyran-2-one  
1HNMR  
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